Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cognition as a parameter in monitoring the effect of multiple sclerosis relapse treatment: A prospective controlled study.
Piri Cinar B, Baba C, Demir S, Uzunkopru C, Seferoglu M, Gungor Dogan I, Cilingir V, Acikgoz M, Bulbul NG, Sivaci AO, Cekic S, Yigit P, Eroglu S, Beckmann Y, Ozakbas S. Piri Cinar B, et al. Among authors: beckmann y. Clin Neurol Neurosurg. 2024 Mar;238:108173. doi: 10.1016/j.clineuro.2024.108173. Epub 2024 Feb 16. Clin Neurol Neurosurg. 2024. PMID: 38430729
Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
Sıvacı AÖ, Seferoğlu M, Piri Çınar B, Uzunköprü C, Beckmann Y, Güngör Doğan İ, Çetinkaya Tezer D, Tunç A, Ethemoğlu Ö, Gümüş H, Açıkgöz M, Yalaz Tekan Ü, Demir S. Sıvacı AÖ, et al. Among authors: beckmann y. Mult Scler Relat Disord. 2024 Apr;84:105469. doi: 10.1016/j.msard.2024.105469. Epub 2024 Feb 1. Mult Scler Relat Disord. 2024. PMID: 38341979
The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis.
Şen S, Arslan G, Tütüncü M, Demir S, Dinç Ö, Gündüz T, Uzunköprü C, Gümüş H, Tütüncü M, Akçin R, Özakbaş S, Köseoğlu M, Bünül SD, Gezer O, Tezer DÇ, Baba C, Özen PA, Koç R, Elverdi T, Uygunoğlu U, Kürtüncü M, Beckmann Y, Doğan İG, Turan ÖF, Boz C, Terzi M, Tuncer A, Saip S, Karabudak R, Kocazeybek B, Efendi H, Bilge U, Siva A. Şen S, et al. Among authors: beckmann y. Noro Psikiyatr Ars. 2023 Aug 10;60(3):252-256. doi: 10.29399/npa.28503. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 37645088 Free PMC article.
Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Terzi M, Helvacı EM, Şen S, Boz C, Çilingir V, Akçalı A, Beckmann Y, Uzunköprü C, Türkoğlu R, Yüceyar N, Efendi H, Destan Bünül S, Seferoğlu M, Kotan D, Güler S, Balcı BP, Öztürk B, Mungan S, İçen NK, Ömerhoca S, Yurtoğulları Ş, Sevim S, Türkoğlu ŞA, Çam M, Yetkin MF, Yoldaş TK, Sıvacı AÖ, Gökçe ŞF, Gürsoy E, Ünal A, Bilge N, Ağan K, Toprak MK, Koçer B, Sözer G, Terzi Y. Terzi M, et al. Among authors: beckmann y. Noro Psikiyatr Ars. 2023 May 25;60(2):190. doi: 10.29399/npa.28499. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 37287556 Free PMC article.
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?
Tütüncü M, Demir S, Arslan G, Dinç Ö, Şen S, Gündüz T, Uzunköprü C, Gümüş H, Tütüncü M, Akçin R, Özakbaş S, Köseoğlu M, Bünül SD, Gezen O, Tezer DÇ, Baba C, Özen PA, Koç R, Elverdi T, Uygunoğlu U, Kürtüncü M, Beckmann Y, Doğan İG, Turan ÖF, Boz C, Terzi M, Tuncer A, Saip S, Karabudak R, Kocazeybek B, Efendi H, Bilge U, Siva A. Tütüncü M, et al. Among authors: beckmann y. Mult Scler Relat Disord. 2023 Jul;75:104761. doi: 10.1016/j.msard.2023.104761. Epub 2023 May 10. Mult Scler Relat Disord. 2023. PMID: 37247488 Free PMC article.
Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).
Tuncer MA, Kürtüncü M, Terzi M, Uygunoğlu U, Göncüoğlu C, Yüceyar AN, Ekmekçi Ö, Türkoğlu R, Soysal A, Köseoğlu M, Boz C, Beckmann Y, Turan ÖF, Demirkıran DM, Akman FG, Altunrende B, Cantürk İA, Birday E, Özcan A, Kamişli Ö, Özen NPA, Çelik RGG, Balcı FB, Efendi H, Sarıkaya C, Akçalı A, Toprak MK, Kabay SC, Kızılay F, Sevim MS, Gazaloğlu GB, Demir CF, Balgetir F, Kıylıoğlu N, Sarıahmetoğlu H, Ölmez Ç, Mavi K, Yüksel S, Işık N, Saip S, Karabudak R, Siva A, Eraksoy M. Tuncer MA, et al. Among authors: beckmann y. Turk J Med Sci. 2023 Feb;53(1):323-332. doi: 10.55730/1300-0144.5588. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945929 Free PMC article.
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Terzi M, Helvacı EM, Şen S, Boz C, Çilingir V, Akçalı A, Beckmann Y, Uzunköprü C, Türkoğlu R, Yüceyar N, Efendi H, Bünül SD, Seferoğlu M, Kotan D, Güler S, Balcı BP, Öztürk B, Mungan S, İçen NK, Ömerhoca S, Yurtoğulları Ş, Sevim S, Türkoğlu ŞA, Çam M, Yetkin MF, Yoldaş TK, Sıvacı AÖ, Gökçe ŞF, Gürsoy E, Ünal A, Bilge N, Ağan K, Toprak MK, Koçer B, Sezer G, Terzi Y. Terzi M, et al. Among authors: beckmann y. Noro Psikiyatr Ars. 2023 Jan 13;60(1):23-27. doi: 10.29399/npa.28081. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 36911568 Free PMC article.
The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in Turkey.
Gündüz T, Uzunköprü C, Demir S, Tütüncü M, Seferoğlu M, Gümüş H, Şen S, Doğan İG, Tütüncü M, Çalikoğlu YS, Beckmann Y, Kocaman AS, Siva A. Gündüz T, et al. Among authors: beckmann y. Noro Psikiyatr Ars. 2022 Aug 15;59(3):226-231. doi: 10.29399/npa.28189. eCollection 2022. Noro Psikiyatr Ars. 2022. PMID: 36160079 Free PMC article.
53 results